In this section
Current research and innovation projects
Herma Heart Institute funded projects
Funding the next wave of advancements in congenital heart disease is not always easy. Learn more about the Herma Heart Institute’s commitment to funding future research.
Below is the latest round of fund recipients for 2019:
- Childhood after Heart-Lung Failure: The Risk Environment and Impact of Mechanical Circulatory Support on Functional Outcomes — Krisjon Rae Olson, Ph.D., Mary Homan, PhD, Michael Mitchell, MD, D. Woodrow Benson, MD, PhD
- Enhancing Healthcare Management of Pediatric Heart Disease by Connecting School Health Plans to Medical Care Teams — Cheryl Brosig, PhD, Pippa Simpson, PhD, Kyle Landry, MS, Christie Ruehl, JD, MBA
- Mechanisms underlying the effects of MYH6 variants in Congenital Heart Disease —Michael Mitchell, MD, Aoy Mitchell, PhD, Sara Creighton, MD, Aron Geurts, PhD, John Lough, PhD, Jeanne James, MD, Robert Fitts, PhD, Jennifer Strande, MD, Pippa Simpson, PhD
- Post-Traumatic Stress Symptoms Quality Improvement — Terri Konkel, RN, Dr. Cheryl Brosig, PhD, Pat Stoll, MSW, Leslie Scott, Laura Rohowetz, PNP, Katie Kogutkiewicz, RN, BSN, Michelle Peritz, RN, BSN, Sydney Allen MPH, David Saudek MD, Mike Mitchell MD
- Improving Care through the Herma Heart Institute’s Clinical Informatics Data Portal — David Saudek, MD, Aaron Kinney, DBA, Julie Lavoie, MSN, RN, Angie Klemm, Stephanie Handler, MD, Nancy Rudd, APNP, Kathy Mussatto, PhD, RN, Francis Kim, MD, Sydney Allen, MPH, Nicholas Peterson
A better way to predict heart transplant rejection
- We are leading a multi-center NIH-funded study that provides a more cost-effective and non-invasive alternative to biopsy testing. While the research continues and expands to include other organs, we are proud to offer this test to our heart transplant families.
A new diagnostic tool for high-risk pregnancies
- We are beginning a four year NIH-funded study that explores the use of fetal magnetocardiography (fMCG), a potentially more accurate test to detect the highest risk pregnancies with fetal heart defects.
- We received a $1.8 million grant from NASA to define the relationship between radiation exposure and heart disease, and determine effective treatments to counteract the negative impacts of exposure.
Virtual health and 3D technology
The Stanford Virtual Heart
- Developed by Lighthaus Inc. with the support of the Betty Irene Moore Children’s Heart Center at Stanford and Oculus VR, the Stanford Virtual Heart is a cutting-edge virtual reality education tool. The Herma Heart Institute is currently one of 20 pediatric hospitals with The Stanford Virtual Heart. Watch this video to learn how else we’re using the Stanford Virtual Heart at the Herma Heart Institute.
The Heart Summit
- Our annual Heart Summit is an immersive experience that gives unprecedented access to the inside of the operating room. Each October, a group of some of the world’s greatest medical minds come to gather to watch an open-heart surgery live in 3D while interacting in real time with the surgeon.
3D surgical encyclopedia
- With the help of our 3D camera, we continue to grow our collection of recorded surgical procedures in a 3D format. These recordings will help enhance education and training for the next wave of providers at peer institutions across the world.
- Along with being the pioneers of the Interstage Home Monitoring approach, we led the way into the next digital frontier by translating the program into an mobile app. This new platform eliminated the need for binders of papers and a flurry of phone calls, and ultimately reduced the stress for parents. Learn about the Interstage Home Monitoring app and other new technologies at our hospital.
The Aoy Tomita-Mitchell and Michael Mitchell congenital heart disease lab
Read more about the congenital heart disease research underway in the Mitchell Lab.